Delayed or delayed sequential bone marrow transplantation: Relevance for acute graft-versus-host disease prevention after major H2 incompatible transplantation

Bone Marrow Transplantation

Volumn 35, Issue 8, 2005, Pages 803-806

  Mabed, Moh ^a   Maroof, S ^a   Zalta, K ^a   El Awadee, M ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Acute graft versus host disease; Delayed bone marrow transplantation; Delayed sequential bone marrow transplantation

Indexed keywords

H2 ANTIGEN;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DEATH; DONOR; FOLLOW UP; HISTOLOGY; MALE; MOUSE; NONHUMAN; PRIMARY PREVENTION; PRIORITY JOURNAL; RECIPIENT; SURVIVAL RATE; WHOLE BODY RADIATION;

ANIMALS; BODY WEIGHT; BONE MARROW TRANSPLANTATION; GRAFT VS HOST DISEASE; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; TIME FACTORS; TRANSPLANTATION CONDITIONING; WHOLE-BODY IRRADIATION;

EID: 18144423878     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704877     Document Type: Article

References (24)

1. Ferrara JL, Levy R, Chao NJ. Pathophysiologic mechanisms of acute graft-versus-host disease. Biol Blood Marrow Transplant 1999; 5: 347-356.
2. Teshima T, Ferrara JL. Understanding the alloresponse: new approaches to graft-versus-host disease prevention. Semin Hematol 2002; 39: 15-22.
3. Schwaighofer H, Kernan NA, O'Reilly RJ et al. Serum levels of cytokines and secondary messages after T-cell depleted and non-T-depleted bone marrow transplantation: influence of conditioning and hematopoietic reconstitution. Transplantation 1996; 62: 947-953.
4. Xun CQ, Thompson JS, Jennings CD et al. Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2-incompatible transplanted SCID mice. Blood 1994; 83: 2360-2367.
5. Holler E, Kolb HJ, Mittermuller J et al. Modulation of acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNF alpha) release in the course of pre-transplant conditioning: role of conditioning regimen and prophylactic application of a monoclonal antibody neutralizing human TNF alpha (MAK 195F). Blood 1995; 86: 890-899.
6. Norton J, Sloane JP. ICAM-1 expression on epidermal keratinocytes in cutaneous graft-versus-host disease. Transplantation 1991; 51: 1203-1206.
7. Gabbianelli M, Boccoli G, Cianetti L et al. HLA expression in hematopoietic development. Class I and II antigens are induced in the definitive erythroid lineage and differentially modulated by fetal liver cytokines. J Immunol 1990; 144: 3354-3360.
8. Thornhil MH, Wellicome SM, Mahiouz DL et al. Tumor necrosis factor combines with IL-4 or IFN-γ to selectively enhance endothelial cell adhesiveness for T cells. J Immunol 1991; 146: 592-598.
9. Holler E, Ertl B, Hintermeier-Knabe R et al. Inflammatory reactions induced by pretransplant conditioning - an alternative target for modulation of acute GvHD and complications following allogeneic bone marrow transplantation. Leuk Lymphoma 1997; 3-4: 217-224.
10. Johnson BD, Drobyski WR, Truitt RL. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease. Bone Marrow Transplant 1993; 11: 329-336.
11. Ferrara JL. Pathogenesis of acute graft-versus-host disease: cytokines and cellular effectors. J Hematother Stem Cell Res 2000; 9: 299-306.
12. Ferrara JL. Cellular and cytokine effectors of acute graft versus host disease. Int J Hematol 2002; 76: 195-198.
13. Kataoka Y, Iwasaki T, Kuroiwa T et al. The role of donor T cells for target organ injuries in acute and chronic graft-versus-host disease. Immunology 2001; 103: 310-318.
14. Hill GR, Ferrara JL. The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rational for the use of cytokine shields in allogeneic bone marrow transplantation. Blood 2000; 95: 2754-2759.
15. Murphy WJ, Blazar BR. New strategies for preventing graft-versus-host-disease. Curr Opin Immunol 1999; 11: 509-515.
16. Wang JH, Redmond HP, Wastson RW, Bouchier-Hayes D. Role of lipopolysacharide and tumor necrosis factor alpha in induction of hepatocyte necrosis. Am J Physiol 1995; 269: G297.
17. Deeg HJ, Spitzer TR, Cottler-Fox M et al. Conditioning-related toxicity and acute graft-versus-host disease in patients given methotrexate/cyclosporine prophylaxis. Bone Marrow Transplant 1991; 7: 193-198.
18. Truitt RL, Atasoylu AA. Impact of pretransplant conditioning and donor T cells on chimerism, graft-versus-host disease, graft-versus-leukemia reactivity and tolerance after bone marrow transplantation. Blood 1991; 77: 2515-2523.
19. Xun CQ, Tsuchida M, Thompson JS. Delaying transplantation after total body irradiation is a simple and effective way to reduce acute graft-versus-host-disease mortality after major H2 incompatible transplantation. Transplantation 1997; 64: 297-302.
20. Tsuchida M, Brown SA, Tutt LM et al. A model of human anti T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes. Clin Transp 1997; 11: 522-528.
21. Xu H, Exner BG, Chilton PM et al. A delay in bone marrow transplantation after partial conditioning improves engraftment. Transplantation 2004; 77: 819-826.
22. Xiang Y, Yang R, Meng X. Experimental study on mice scheduled-bone marrow transplantation. Zhonghua Xue Ye Xue Za Zhi 1998; 12: 634-637.
23. Johnson BD, Truitt RL. Delayed infusion of immunocompetent donor cells after bone marrow transplantation breaks graft-host tolerance allows for persistent antileukemic reactivity without severe graft-versus-host disease. Blood 1995; 85: 3302-3312.
24. Johnson BD, Becker EE, Truitt RL. Graft-vs-host and graft-vs-leukemia reactions after delayed infusions of donor T-subsets. Biol Blood Marrow Transplant 1999; 5: 123-132.